Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Notes Payables (2016 - 2018)

Historic Notes Payables for Lisata Therapeutics (LSTA) over the last 9 years, with Q2 2018 value amounting to $23289.0.

  • Lisata Therapeutics' Notes Payables fell 9611.85% to $23289.0 in Q2 2018 from the same period last year, while for Jun 2018 it was $23289.0, marking a year-over-year decrease of 9611.85%. This contributed to the annual value of $159000.0 for FY2017, which is 7728.57% down from last year.
  • According to the latest figures from Q2 2018, Lisata Therapeutics' Notes Payables is $23289.0, which was down 9611.85% from $100000.0 recorded in Q1 2018.
  • In the past 5 years, Lisata Therapeutics' Notes Payables ranged from a high of $2.1 million in Q2 2015 and a low of $23289.0 during Q2 2018
  • In the last 5 years, Lisata Therapeutics' Notes Payables had a median value of $1.2 million in 2016 and averaged $1.2 million.
  • As far as peak fluctuations go, Lisata Therapeutics' Notes Payables surged by 46666.67% in 2014, and later tumbled by 9611.85% in 2018.
  • Over the past 5 years, Lisata Therapeutics' Notes Payables (Quarter) stood at $1.6 million in 2014, then crashed by 31.25% to $1.1 million in 2015, then plummeted by 36.36% to $700000.0 in 2016, then tumbled by 77.29% to $159000.0 in 2017, then crashed by 85.35% to $23289.0 in 2018.
  • Its last three reported values are $23289.0 in Q2 2018, $100000.0 for Q1 2018, and $159000.0 during Q4 2017.